The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
RELEVANCE: Phase III randomized study of lenalidomide plus rituximab (R2) versus chemotherapy plus rituximab, followed by rituximab maintenance, in patients with previously untreated follicular lymphoma.
 
Nathan Hale Fowler
Consulting or Advisory Role - Abbvie; Celgene; Merck; Roche
Research Funding - Abbvie; Celgene; Janssen; Roche
 
Franck Morschhauser
Honoraria - Bristol-Myers Squibb; Gilead Sciences; Janssen
Consulting or Advisory Role - Celgene; Gilead Sciences; Roche
 
Pierre Feugier
Honoraria - Gilead Sciences; Janssen; Roche
Consulting or Advisory Role - Gilead Sciences; Janssen; Roche
Research Funding - Gilead Sciences; Janssen; Roche
Travel, Accommodations, Expenses - Celgene; Gilead Sciences; Janssen; Roche
 
Reda Bouabdallah
No Relationships to Disclose
 
Herve Tilly
Honoraria - Celgene; Roche/Genentech; SERVIER
Consulting or Advisory Role - AstraZeneca; Karyopharm Therapeutics; Roche
Research Funding - Celgene (Inst)
Travel, Accommodations, Expenses - Roche
 
Maria Lia Palomba
Consulting or Advisory Role - Celgene; Merck; Pharmacyclics
 
Christophe Fruchart
No Relationships to Disclose
 
Edward N. Libby
No Relationships to Disclose
 
Olivier Casasnovas
Honoraria - Abbvie; Bristol-Myers Squibb; Celgene; Gilead Sciences; Merck; Roche/Genentech; Sanofi; Takeda
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb; Celgene; Gilead Sciences; Merck; Roche/Genentech; Takeda
Research Funding - Gilead Sciences (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Gilead Sciences; Janssen; Roche/Genentech; Takeda
 
Maria Gomes Da Silva
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb; Celgene; Gilead Sciences; Janssen-Cilag; Roche; Takeda
Speakers' Bureau - Bristol-Myers Squibb; Celgene; Ferrer; Janssen-Cilag; Takeda
Research Funding - Gilead Sciences
Travel, Accommodations, Expenses - Celgene; Gilead Sciences; Janssen-Cilag; Roche
 
Delphine Pranger
No Relationships to Disclose
 
Pierre Zachee
No Relationships to Disclose
 
Alejandro Martin Garcia-Sancho
Honoraria - Janssen; Roche; SERVIER
Consulting or Advisory Role - Celgene
Research Funding - Celgene; Janssen; Teva
Travel, Accommodations, Expenses - Celgene; Roche
 
Armando Lopez-Guillermo
Consulting or Advisory Role - Celgene; Gilead Sciences; Janssen; Novartis; Roche
Research Funding - Celgene; Roche
 
Jean-Francois Larouche
Research Funding - Bayer; Gilead Sciences; Merck; Roche
 
Kiyoshi Ando
No Relationships to Disclose
 
Dongfang Liu
Employment - Bristol-Myers Squibb; Celgene
Stock and Other Ownership Interests - Bristol-Myers Squibb; Celgene
Patents, Royalties, Other Intellectual Property - Momenta Pharmaceuticals
 
Jianming Wang
Employment - Celgene
Stock and Other Ownership Interests - Celgene
 
Luc Xerri
Travel, Accommodations, Expenses - Janssen
 
Gilles A. Salles
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Gilead Sciences; Gilead Sciences; Janssen; Novartis; Roche/Genentech; SERVIER
Consulting or Advisory Role - Acerta Pharma; Bristol-Myers Squibb; Celgene; Gilead Sciences; Janssen; Kite, a Gilead company; Merck; Novartis; Novimmune; Pfizer; Roche/Genentech; SERVIER
Research Funding - Celgene; Gilead Sciences; Merck; Roche/Genentech; Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Roche/Genentech; Sanofi